Author:
Kurebayashi J,Otsuki T,Tang C K,Kurosumi M,Yamamoto S,Tanaka K,Mochizuki M,Nakamura H,Soono H
Publisher
Springer Science and Business Media LLC
Reference36 articles.
1. Alimandi, M., Wang, L-M, Bottaro, D., Lee, C-C, Kuo, A., Frankel, M., Fedi, P., Tang, C., Lippman, M. & Pierce, J. H. (1997). Epidermal growth factor and betacellulin mediate signal transduction through coexpressed Erb B2 and Erb B3 receptors. EMBO J, 16, 5608–5617.
2. Band, V., Zajchowski, D., Stenman, G., Morton, C. C., Kulesa, V., Connolly, J. & Sager, R. (1989). A newly established metastatic breast tumor cell line with integrated amplified copies of ERB B2 and double minute chromosomes. Genes Chromosomes Cancer, 1, 48–58.
3. Baselga, J., Tripathy, D., Mendelsohn, J., Baughman, S., Benz, C. C., Dantis, L., Sklarin, N. T., Seidman, A. D., Hudis, C. A., Moore, J., Rosen, P. P., Twaddell, T., Henderson, I. C. & Norton, L. (1996). Phase II study of weekly intravenous recombinant humanized anti-p185HER2monoclonal antibody in patients with HER2/neu overexpressing metastatic breast cancer. J Clin Oncol, 14, 737–744.
4. Baselga, J., Norton, L., Albanell, J., Kim, Y-M & Mendelsohn, J. (1998). Recombinant humanized anti-HER2 antibody (HerceptinTM) enhances the antitumour activity of paclitaxel and doxorubicin against HER2/neu overexpressiong human breast cancer xenografts. Cancer Res, 58, 2825–2831.
5. Beerli, R. R., Graus-Porta, D., Woods-Cook, K., Chen, X., Yarden, Y. & Hynes, N. E. (1995). Neu differentiation factor activation of ErbB-3 and ErbB-4 is cell specific and displays a differential requirement for ErbB-2. Mol Cell Biol, 15, 6496–6505.
Cited by
171 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献